Inhibition of p38 kinase activity by aryl ureas
1998
(57) Abstract: The present invention relates to the use of a group of aryl ureas in treating cytokine mediated diseases and proteolytic enzyme mediated diseases other than cancer than cancer, as well as pharmaceutical compositions for use in such treatments for .
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI